<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A young lady who had aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> presented for <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> after five years of follow up </plain></SENT>
<SENT sid="1" pm="."><plain>She was diagnosed to have <z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">paroxysmal nocturnal haemoglobinuria</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>She had received immunosuppressive therapy with <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>, <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>-A, anti-lymphocyte globulin, <z:chebi fb="1" ids="4315">danazol</z:chebi> and <z:chebi fb="0" ids="16581">pregnenolone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The relation between aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo>, <z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">paroxysmal nocturnal haemoglobinuria</z:e> and <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> is discussed </plain></SENT>
<SENT sid="4" pm="."><plain>The role of immunosuppressive therapy for aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> in causation of <z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">paroxysmal nocturnal haemoglobinuria</z:e> is reviewed </plain></SENT>
</text></document>